Helping Hand Program for Osteoarthritis
("Helping Hand" Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems you can continue your usual care, which may include your current medications.
What data supports the effectiveness of the Helping Hand - Joint Protection Program treatment for osteoarthritis?
Is the Helping Hand Program for Osteoarthritis safe for humans?
How is the Helping Hand - Joint Protection Program treatment different from other treatments for hand osteoarthritis?
The Helping Hand - Joint Protection Program is unique because it likely combines multidisciplinary and multidimensional approaches, which are not commonly described in existing treatments for hand osteoarthritis. This program may include elements like exercise therapy, self-management, and education, delivered in a novel way to improve adherence and effectiveness.59101112
What is the purpose of this trial?
The goal of this study is to to examine the feasibility of a full-scale trial on Helping Hand, a new Joint Protection Program for Hand Osteoarthritis and to examine the acceptability of the new Joint Protection Program.This study will not assess the effectiveness of the program, as it is not designed or powered to do so. Instead, the information gathered will be used to refine the trial design and ensure the future full-scale trial that will assess the effectiveness of the program is robust and successful. The acceptability of the new Joint Protection Program will be assessed through a survey that will be administered to the intervention group at the end of the trial, which will be based on a standardized acceptability frameworkParticipants will:Gain access to an online Joint Protection Program or continue to receive usual care for 12 weeks Visit the clinic or complete online assessments once every 4 weeks Keep a diary of their symptoms and the number of times they used other interventions to manage their symptoms (i.e. painkillers)
Eligibility Criteria
This trial is for individuals with hand osteoarthritis who have been in pain for at least three months. Participants must be able to use digital devices and communicate in English. It's not suitable for those planning hand surgery soon or with neurological disorders, dementia, or cognitive conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants gain access to an online Joint Protection Program or continue to receive usual care for 12 weeks
Follow-up
Participants are monitored for adherence and acceptability of the Joint Protection Program
Treatment Details
Interventions
- Helping Hand - Joint Protection Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
The Arthritis Society, Canada
Collaborator